Natera (NTRA) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free NTRA Stock Alerts $106.46 -2.04 (-1.88%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 5:24 AM | americanbankingnews.comSteven Leonard Chapman Sells 6,779 Shares of Natera, Inc. (NASDAQ:NTRA) StockMay 18 at 9:33 AM | insidertrades.comNatera, Inc. (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 6,779 SharesMay 18 at 6:54 AM | marketbeat.comMassachusetts Financial Services Co. MA Invests $27.63 Million in Natera, Inc. (NASDAQ:NTRA)Massachusetts Financial Services Co. MA bought a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 441,024 shares of the medical research company's stock, valued at approximately $27,626,000. MassacMay 18 at 2:26 AM | americanbankingnews.comNatera, Inc. (NASDAQ:NTRA) Given Consensus Rating of "Buy" by AnalystsMay 18 at 12:36 AM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CEO Sells $725,895.32 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 6,779 shares of the stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $107.08, for a total transaction of $725,895.32. Following the completion of the transaction, the chief executive officer now directly owns 219,456 shares in the company, valued at $23,499,348.48. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.May 17 at 6:20 AM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Bought by BNP Paribas Financial MarketsBNP Paribas Financial Markets increased its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 375.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 183,375 shares of the medical research company's stock after purchasing aMay 17 at 3:40 AM | americanbankingnews.comNatera (NASDAQ:NTRA) Upgraded by StockNews.com to "Hold"May 16 at 8:04 PM | marketbeat.comNatera (NASDAQ:NTRA) Sets New 12-Month High at $108.51Natera (NASDAQ:NTRA) Sets New 12-Month High at $108.51May 16 at 7:56 AM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Acquired by Jump Financial LLCJump Financial LLC lifted its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 128.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,221 shares of the medical research company's stock after acquiMay 16 at 4:28 AM | americanbankingnews.comNatera (NASDAQ:NTRA) PT Raised to $120.00May 15, 2024 | americanbankingnews.comNatera (NASDAQ:NTRA) PT Raised to $125.00 at BTIG ResearchMay 14, 2024 | marketbeat.comNatera (NASDAQ:NTRA) Price Target Raised to $120.00Piper Sandler raised their price target on shares of Natera from $110.00 to $120.00 and gave the stock an "overweight" rating in a report on Tuesday.May 14, 2024 | americanbankingnews.comNatera (NASDAQ:NTRA) Given New $137.00 Price Target at TD CowenMay 13, 2024 | markets.businessinsider.comKey Takeaways From Natera Analyst RatingsMay 13, 2024 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Bought by Principal Financial Group Inc.Principal Financial Group Inc. raised its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 7.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,703,615 shares of the medical research company's stocMay 13, 2024 | marketbeat.comNatera (NASDAQ:NTRA) Price Target Raised to $125.00 at BTIG ResearchBTIG Research boosted their target price on Natera from $100.00 to $125.00 and gave the company a "buy" rating in a report on Monday.May 13, 2024 | americanbankingnews.comNatera (NASDAQ:NTRA) Price Target Raised to $117.00May 12, 2024 | seekingalpha.comNatera, Inc. (NTRA) Q1 2024 Earnings Call TranscriptMay 12, 2024 | marketbeat.comHamilton Lane Advisors LLC Buys Shares of 9,833 Natera, Inc. (NASDAQ:NTRA)Hamilton Lane Advisors LLC bought a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 9,833 shares of the medical research company's stock, valued at approximately $616,000. NaMay 12, 2024 | americanbankingnews.comCanaccord Genuity Group Increases Natera (NASDAQ:NTRA) Price Target to $130.00May 12, 2024 | americanbankingnews.comDaniel Rabinowitz Sells 30,000 Shares of Natera, Inc. (NASDAQ:NTRA) StockMay 11, 2024 | insidertrades.comNatera, Inc. (NASDAQ:NTRA) Insider Sells $3,137,700.00 in StockMay 11, 2024 | finance.yahoo.comNatera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024May 11, 2024 | marketbeat.comSwiss National Bank Sells 16,600 Shares of Natera, Inc. (NASDAQ:NTRA)Swiss National Bank trimmed its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 7.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 222,100 shares of the medical research company's stock after selling 16,600May 11, 2024 | americanbankingnews.comStockNews.com Downgrades Natera (NASDAQ:NTRA) to SellMay 11, 2024 | americanbankingnews.comNatera (NASDAQ:NTRA) Reaches New 12-Month High After Earnings BeatMay 10, 2024 | marketbeat.comNatera (NASDAQ:NTRA) Announces Earnings Results, Beats Expectations By $0.16 EPSNatera (NASDAQ:NTRA - Get Free Report) issued its quarterly earnings results on Thursday. The medical research company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.72) by $0.16. Natera had a negative return on equity of 62.19% and a negative net margin of 40.16%. The company had revenue of $367.70 million for the quarter, compared to analyst estimates of $316.31 million. The company's revenue for the quarter was up 52.1% compared to the same quarter last year. During the same quarter last year, the company posted ($1.23) EPS.May 10, 2024 | benzinga.comWhy Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving PremarketMay 10, 2024 | msn.comNatera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comNatera (NASDAQ:NTRA) Reaches New 1-Year High After Earnings BeatNatera (NASDAQ:NTRA) Reaches New 12-Month High Following Strong EarningsMay 9, 2024 | msn.comNTRA Stock Earnings: Natera Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | businesswire.comNatera Reports First Quarter 2024 Financial ResultsMay 9, 2024 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Truist Financial CorpTruist Financial Corp lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 18.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,166 shares of the medical research company's stock after selling 8,644May 7, 2024 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Natera (NTRA)May 5, 2024 | stockhouse.comNew Natera Publication Bolsters Evidence for Extended Surveillance with Signatera(TM) in Breast CancerMay 5, 2024 | marketbeat.comVan ECK Associates Corp Sells 15,277 Shares of Natera, Inc. (NASDAQ:NTRA)Van ECK Associates Corp lowered its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 13.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,601 shares of the mMay 5, 2024 | insidertrades.comMichael Burkes Brophy Sells 1,866 Shares of Natera, Inc. (NASDAQ:NTRA) StockMay 3, 2024 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 1,866 SharesNatera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 1,866 shares of the stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $93.97, for a total transaction of $175,348.02. Following the completion of the sale, the chief financial officer now directly owns 67,542 shares in the company, valued at approximately $6,346,921.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.May 3, 2024 | businesswire.comNew Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast CancerMay 2, 2024 | finance.yahoo.comInsider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)May 2, 2024 | finance.yahoo.comInsider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)May 2, 2024 | insidertrades.comNatera, Inc. (NASDAQ:NTRA) Insider John Fesko Sells 929 SharesMay 1, 2024 | finance.yahoo.comNatera to Report its First Quarter 2024 Results on May 9May 1, 2024 | businesswire.comNatera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg ShortageApril 29, 2024 | marketbeat.com51,308 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by abrdn plcabrdn plc purchased a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 51,308 shares of the medical research company's stock, valued at approximately $3,214,000. A number of othApril 28, 2024 | investing.comNatera co-founder sells $89,550 in company stockApril 27, 2024 | insidertrades.comNatera, Inc. (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 705 SharesApril 27, 2024 | finance.yahoo.comInsider Sell: CFO Michael Brophy Sells Shares of Natera IncApril 26, 2024 | marketbeat.comJennison Associates LLC Takes $13.33 Million Position in Natera, Inc. (NASDAQ:NTRA)Jennison Associates LLC bought a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 212,811 shares of the medical researApril 25, 2024 | investing.comNatera's chief legal officer executes stock transactions Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. NTRA Media Mentions By Week NTRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRA News Sentiment▼0.760.42▲Average Medical News Sentiment NTRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRA Articles This Week▼226▲NTRA Articles Average Week Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DGX News Today EXAS News Today LH News Today RDNT News Today FMS News Today THC News Today INCY News Today SRPT News Today SWAV News Today MEDP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTRA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & CompanyProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
